Cargando…

Heterogeneous Characteristics of Korean Patients with Dysferlinopathy

Dysferlinopathy is caused by mutations in the DYSF gene. To characterize the clinical spectrum, we investigated the characteristics of 31 Korean dysferlinopathy patients confirmed by immunohistochemistry. The mean age of symptom onset was 22.23 ± 7.34 yr. The serum creatine kinase (CK) was highly in...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyung Jun, Hong, Ji-Man, Suh, Gyoung Im, Shin, Ha Young, Kim, Seung Min, Sunwoo, Il Nam, Suh, Bum Chun, Choi, Young-Chul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Academy of Medical Sciences 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314856/
https://www.ncbi.nlm.nih.gov/pubmed/22468107
http://dx.doi.org/10.3346/jkms.2012.27.4.423
_version_ 1782228153170657280
author Park, Hyung Jun
Hong, Ji-Man
Suh, Gyoung Im
Shin, Ha Young
Kim, Seung Min
Sunwoo, Il Nam
Suh, Bum Chun
Choi, Young-Chul
author_facet Park, Hyung Jun
Hong, Ji-Man
Suh, Gyoung Im
Shin, Ha Young
Kim, Seung Min
Sunwoo, Il Nam
Suh, Bum Chun
Choi, Young-Chul
author_sort Park, Hyung Jun
collection PubMed
description Dysferlinopathy is caused by mutations in the DYSF gene. To characterize the clinical spectrum, we investigated the characteristics of 31 Korean dysferlinopathy patients confirmed by immunohistochemistry. The mean age of symptom onset was 22.23 ± 7.34 yr. The serum creatine kinase (CK) was highly increased (4- to 101-fold above normal). The pathological findings of muscle specimens showed nonspecific dystrophic features and frequent inflammatory cell infiltration. Muscle imaging studies showed fatty atrophic changes dominantly in the posterolateral muscles of the lower limb. The patients with dysferlinopathy were classified by initial muscle weakness: fifteen patients with Miyoshi myopathy phenotype (MM), thirteen patients with limb girdle muscular dystrophy 2B phenotype (LGMD2B), two patients with proximodistal phenotype, and one asymptomatic patient. There were no differences between LGMD2B and MM groups in terms of onset age, serum CK levels and pathological findings. Dysferlinopathy patients usually have young adult onset and high serum CK levels. However, heterogeneity of clinical presentations and pathologic findings upon routine staining makes it difficult to diagnose dysferlinopathy. These limitations make immunohistochemistry currently the most important method for the diagnosis of dysferlinopathy.
format Online
Article
Text
id pubmed-3314856
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher The Korean Academy of Medical Sciences
record_format MEDLINE/PubMed
spelling pubmed-33148562012-04-01 Heterogeneous Characteristics of Korean Patients with Dysferlinopathy Park, Hyung Jun Hong, Ji-Man Suh, Gyoung Im Shin, Ha Young Kim, Seung Min Sunwoo, Il Nam Suh, Bum Chun Choi, Young-Chul J Korean Med Sci Original Article Dysferlinopathy is caused by mutations in the DYSF gene. To characterize the clinical spectrum, we investigated the characteristics of 31 Korean dysferlinopathy patients confirmed by immunohistochemistry. The mean age of symptom onset was 22.23 ± 7.34 yr. The serum creatine kinase (CK) was highly increased (4- to 101-fold above normal). The pathological findings of muscle specimens showed nonspecific dystrophic features and frequent inflammatory cell infiltration. Muscle imaging studies showed fatty atrophic changes dominantly in the posterolateral muscles of the lower limb. The patients with dysferlinopathy were classified by initial muscle weakness: fifteen patients with Miyoshi myopathy phenotype (MM), thirteen patients with limb girdle muscular dystrophy 2B phenotype (LGMD2B), two patients with proximodistal phenotype, and one asymptomatic patient. There were no differences between LGMD2B and MM groups in terms of onset age, serum CK levels and pathological findings. Dysferlinopathy patients usually have young adult onset and high serum CK levels. However, heterogeneity of clinical presentations and pathologic findings upon routine staining makes it difficult to diagnose dysferlinopathy. These limitations make immunohistochemistry currently the most important method for the diagnosis of dysferlinopathy. The Korean Academy of Medical Sciences 2012-04 2012-03-21 /pmc/articles/PMC3314856/ /pubmed/22468107 http://dx.doi.org/10.3346/jkms.2012.27.4.423 Text en © 2012 The Korean Academy of Medical Sciences. http://creativecommons.org/licenses/by-nc/3.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Park, Hyung Jun
Hong, Ji-Man
Suh, Gyoung Im
Shin, Ha Young
Kim, Seung Min
Sunwoo, Il Nam
Suh, Bum Chun
Choi, Young-Chul
Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
title Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
title_full Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
title_fullStr Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
title_full_unstemmed Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
title_short Heterogeneous Characteristics of Korean Patients with Dysferlinopathy
title_sort heterogeneous characteristics of korean patients with dysferlinopathy
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3314856/
https://www.ncbi.nlm.nih.gov/pubmed/22468107
http://dx.doi.org/10.3346/jkms.2012.27.4.423
work_keys_str_mv AT parkhyungjun heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy
AT hongjiman heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy
AT suhgyoungim heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy
AT shinhayoung heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy
AT kimseungmin heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy
AT sunwooilnam heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy
AT suhbumchun heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy
AT choiyoungchul heterogeneouscharacteristicsofkoreanpatientswithdysferlinopathy